Product ID |
Product Name |
CAS# |
Purity |
Y3288182 |
2-(1,1-dimethyl-1,3-dihydroisobenzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
1613260-40-4 |
95% |
Y3304838 |
WAY-656935 |
852902-81-9 |
98% |
Y3295185 |
GSK3-IN-3 |
331963-27-0 |
98% |
Y3309287 |
WAY-620472 |
686769-90-4 |
98% |
Y3163740 |
1-(trifluoromethyl)cyclopentane-1-carbaldehyde |
371917-30-5 |
95% |
Y3167357 |
Firazorexton |
2274802-95-6 |
99.94% |
Y3307987 |
AGI-14100 |
1448346-43-7 |
100% |
Y3169185 |
5-methyl-2,3-diphenyl-6-(quinolin-6-yl)-4H,7H-pyrazolo[1,5-a]pyrimidin-7-one |
2201065-84-9 |
97% |
Y3309670 |
BILB 1941 |
494856-61-0 |
98% |
Y3305136 |
Seglitide acetate |
99248-33-6 |
98% |
Y3308864 |
SI-2 |
223788-33-8 |
98% |
Y3305698 |
Silperisone HCl |
140944-30-5 |
99% |
Y3297442 |
BRD2492 |
1821669-43-5 |
99% |
Y3305753 |
CPS-11 |
145945-21-7 |
99% |
Y3310316 |
CT-1 |
1983924-33-9 |
99% |
Y3292340 |
Dasantafil |
569351-91-3 |
95% |
Y3309848 |
1,2,3,4-Tetrahydro-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-2-(5-pyrimidinyl)-7-isoquinolinecarboxamide |
1912357-12-0 |
97% |
Y3305133 |
P-2281 |
1112994-35-0 |
99% |
Y3311529 |
JAK 3i |
1918238-72-8 |
99% |
Y3295510 |
JG26 |
1464910-32-4 |
98% |
Y3311374 |
K00135 |
869650-21-5 |
97% |
Y3318100 |
MBC-11 |
332863-86-2 |
100% |
Y3306427 |
MDK-6983 |
1227476-98-3 |
97% |
Y3164394 |
MMRi64 |
430458-66-5 |
98% |
Y3292874 |
ND-322 hydrochloride |
1333379-23-9 |
98% |
Y3308350 |
Nortopixantrone HCl |
438244-41-8 |
97% |
Y3162145 |
2-(7-methyl-1H-indol-3-yl)quinoline |
218464-59-6 |
99% |
Y3311943 |
YM-53403 |
851331-05-0 |
98% |
Y3163626 |
Yonkenafil hydrochloride |
804519-64-0 |
99% |
Y3289242 |
ZEN-2759 |
1616400-50-0 |
99% |
Y3304986 |
Antitumor agent-2 |
1351163-57-9 |
100% |
Y3289133 |
MARK-IN-2 |
1314893-26-9 |
99% |
Y3294527 |
MK-0952 |
934995-87-6 |
99% |
Y3309524 |
OSMI-3 |
2260791-13-5 |
100% |
Y3310996 |
BI-1408 |
2231075-94-6 |
100% |
Y3292856 |
BMS641 |
369364-50-1 |
98% |
Y3293339 |
bPiDI |
525596-64-9 |
99% |
Y3173859 |
5,6-dimethoxypyrazin-2-amine |
89465-07-6 |
95% |
Y3308363 |
2-bromo-4-(tert-butyl)-6-chloroaniline |
2386160-27-4 |
97% |
Y3317152 |
Tetrahydroauroglaucin |
40434-07-9 |
95% |
Y3166709 |
Lipid 8 |
2226547-25-5 |
95.0% |
Y3165008 |
[1-(hydroxymethyl)-3-methylidenecyclobutyl]methanol |
2170372-19-5 |
95% |
Y3161130 |
1-amino-3-azabicyclo[3.1.1]heptane-2,4-dione hydrochloride |
2580207-01-6 |
95% |
Y3164844 |
2-bromo-4-chloropyrazolo[1,5-a]pyrazine |
2751610-55-4 |
95% |
Y3286030 |
FAP-IN-2 |
2471983-20-5 |
99% |
Y3293333 |
(R)-Pirtobrutinib |
2101700-14-3 |
99% |
Y3159020 |
methyl 3-fluoro-4-methylpyridine-2-carboxylate |
1427366-26-4 |
95% |
Y3291850 |
Ritlecitinib tosylate |
2192215-81-7 |
99% |
Y3158337 |
6-hydrazinyl-N,N-dimethylpyridine-3-sulfonamide |
627836-81-1 |
95% |
Y3317100 |
1-(2-methoxyphenyl)-2,2-dimethylpropan-1-ol |
53847-36-2 |
97% |
Y3162075 |
PSMA-ALB-56 |
2306049-48-7 |
98% |
Y3161874 |
L-Cystine-34S2 |
113512-08-6 |
98% |
Y3115005 |
2-(1-Hydroxycyclohexyl)-1-phenylethanone |
57213-26-0 |
95%+ |
Y3307780 |
Sodium 3-methyl-2-oxobutanoate-13C4,d4 |
1185115-88-1 |
98% |
Y3305788 |
98N12-5 |
917572-74-8 |
98% |
Y3164191 |
JPE-1375 |
1254036-23-1 |
99% |
Y3164199 |
tert-butyl 2-(1-amino-2-methylpropan-2-yl)pyrrolidine-1-carboxylate |
2228180-16-1 |
95% |
Y3169895 |
2-(5-bromo-2-methylphenyl)propanoic acid |
1518922-18-3 |
95% |
Y3169617 |
5-(2-bromoethyl)-2-fluorobenzonitrile |
1428478-55-0 |
95% |
Y3163676 |
2-(3-bromo-4-methylphenyl)propanoic acid |
68718-13-8 |
95% |
Y3164469 |
3-(bromomethyl)-N-ethylbenzamide |
1225808-41-2 |
95% |
Y3169636 |
3-cyclobutyl-2,2-difluoropropanoic acid |
1780905-32-9 |
95% |
Y3289909 |
FAP-2286 |
2581741-18-4 |
99% |
Y3163462 |
1-methyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidine-4-thione |
765220-50-6 |
98% |
Y3309233 |
KS106 |
2408477-50-7 |
99% |
Y3163463 |
1-(5-bromo-2-fluorophenyl)ethan-1-aminehydrochloride |
2470441-30-4 |
95% |
Y3164225 |
6'-bromo-2',3'-dihydro-1'H-spiro[cyclobutane-1,4'-isoquinoline]-1'-one |
1780107-29-0 |
95% |
Y3164362 |
7-bromo-1,2,3,4-tetrahydrospiro[2-benzazepine-5,1'-cyclopropan]-1-one |
2680539-03-9 |
95% |
Y3162268 |
7-bromo-5,5-dimethyl-2,3,4,5-tetrahydro-1H-2-benzazepin-1-one |
2680534-82-9 |
95% |
Y3292931 |
4-(Dichloromethyl)-2,6-bis(1,1-dimethylethyl)-4-methyl-2,5-cyclohexadien-1-one |
54537-87-0 |
95% |
Y3164359 |
4-bromo-3-chlorothiophene-2-carboxylicacid |
1401992-28-6 |
95% |
Y3164360 |
(1S)-1-(2-bromo-5-chlorophenyl)ethan-1-aminehydrochloride |
2343963-73-3 |
95% |
Y3286509 |
tert-butyl3-(aminomethyl)-3-(5-fluoropyridin-2-yl)azetidine-1-carboxylate |
2361636-08-8 |
95% |
Y3162271 |
3-(1-benzofuran-3-yl)-2-{[(tert-butoxy)carbonyl]amino}propanoicacid |
74884-01-8 |
95% |
Y3165356 |
7-bromo-2-phenyl-1,3-benzothiazole |
36247-07-1 |
95% |
Y3165480 |
METHYL 8-BROMOIMIDAZO[1,2-A]PYRIDINE-5-CARBOXYLATE |
1312697-72-5 |
95% |
Y3179665 |
N-(benzyloxy)-1-[4-(trifluoromethyl)phenyl]formamido2,2-dimethylpropanoate |
2648454-31-1 |
93% |
Y3179736 |
8-chloro-[1,2,4]triazolo[4,3-a]pyrazin-3-amine |
1339409-33-4 |
95% |
Y3165203 |
2,4-dichloro-6-methanesulfonylpyrimidine |
1048389-45-2 |
95% |
Y3174225 |
rac-(3R,4S)-1-[(tert-butoxy)carbonyl]-4-methoxypyrrolidine-3-carboxylicacid,trans |
2382100-41-4 |
95% |
Y3179738 |
4-[(tert-butoxy)carbonyl]-4-azaspiro[2.4]heptane-5-carboxylicacid |
1779469-52-1 |
95% |
Y3170780 |
3-[methyl(pentan-2-yl)amino]propanoicacidhydrochloride |
2375269-26-2 |
95% |
Y3179739 |
3-[methyl(pentan-3-yl)amino]propanoic acid hydrochloride |
2375259-24-6 |
95% |
Y3164660 |
benzyl 4-oxo-3H,4H,5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carboxylate |
1800483-56-0 |
95% |
Y3161022 |
2-methylidene-7-oxaspiro[3.5]nonane |
2803862-55-5 |
95% |
Y3166235 |
2-[4-(prop-2-yn-1-yloxy)butoxy]aceticacid |
2408962-99-0 |
95% |
Y3161023 |
1-oxo-2-azaspiro[4.5]decane-8-carboxylic acid |
2919945-69-8 |
95% |
Y3312566 |
(6-Nitropyridin-3-yl)methanol |
1935998-46-1 |
97% |
Y3179648 |
methyl7-methoxy-1H-indazole-5-carboxylate |
1427438-43-4 |
95% |
Y3179724 |
(5-bromopyridin-2-yl)(imino)methyl-lambda6-sulfanone |
1632310-37-2 |
95% |
Y3291122 |
2-Chloro-3-fluoro-6-methyl-4-pyridinamine |
2864417-86-5 |
98% |
Y3314840 |
C12-SPM |
2055647-81-7 |
95%+ |
Y3307953 |
tert-butyl (3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decane-8-carboxylate |
2414487-46-8 |
95%+ |
Y3169928 |
7-bromo-2,3-dihydro-1-benzofuran-5-carboxylicacid |
335671-77-7 |
95% |
Y3163840 |
6,8-dichloroisoquinoline |
73075-61-3 |
95% |
Y3114674 |
tert-Butyl (1S,2R,5R)-2-(hydroxymethyl)-3,8-diazabicyclo[3.2.1]octane-8-carboxylate |
2834759-51-0 |
97% |
Y3169931 |
tert-butyl3-iodo-2-methyl-2H,4H,5H,6H-pyrrolo[3,4-c]pyrazole-5-carboxylate |
2601393-69-3 |
95% |
Y3163596 |
3-fluoro-2,6-dimethoxybenzaldehyde |
1286216-61-2 |
95% |
Y3163597 |
3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}cyclobutane-1-carboxylicacid |
2355617-42-2 |
95% |
Y3307472 |
5-Cyclopropylpyrazine-2-carboxylic acid |
1211537-40-4 |
98% |